Ansiolisina en es it fr

Ansiolisina Brand names, Ansiolisina Analogs

Ansiolisina Brand Names Mixture

  • No information avaliable

Ansiolisina Chemical_Formula


Ansiolisina RX_link

Ansiolisina fda sheet

Ansiolisina msds (material safety sheet)

Ansiolisina MSDS

Ansiolisina Synthesis Reference

Reeder, Sternbach; U.S. Pat. 3,371,085 (1968)

Ansiolisina Molecular Weight

284.74 g/mol

Ansiolisina Melting Point


Ansiolisina H2O Solubility

Slightly soluble (50 mg/L)

Ansiolisina State


Ansiolisina LogP


Ansiolisina Dosage Forms

Tablets; Injectable solution

Ansiolisina Indication

Used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome.

Ansiolisina Pharmacology

Diazepam, a benzodiazepine, generates the same active metabolite as chlordiazepoxide and clorazepate. In animals, diazepam appears to act on parts of the limbic system, the thalamus and hypothalamus, and induces calming effects. Diazepam, unlike chlorpromazine and reserpine, has no demonstrable peripheral autonomic blocking action, nor does it produce extrapyramidal side effects; however, animals treated with diazepam do have a transient ataxia at higher doses. Diazepam was found to have transient cardiovascular depressor effects in dogs. Long-term experiments in rats revealed no disturbances of endocrine function. Injections into animals have produced localized irritation of tissue surrounding injection sites and some thickening of veins after intravenous use.

Ansiolisina Absorption

Essentially complete, with a bioavailability of 93%.

Ansiolisina side effects and Toxicity

Symptoms of overdose include somnolence, confusion, coma, and diminished reflexes. Respiration, pulse and blood pressure should be monitored.

Ansiolisina Patient Information

Ansiolisina Organisms Affected

Humans and other mammals